These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mitochondria as a pharmacological target: magnum overview. Olszewska A; Szewczyk A IUBMB Life; 2013 Mar; 65(3):273-81. PubMed ID: 23441041 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review. Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. Beal MF J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876 [TBL] [Abstract][Full Text] [Related]
10. Mitophagy in neurodegeneration: an opportunity for therapy? Santos RX; Correia SC; Carvalho C; Cardoso S; Santos MS; Moreira PI Curr Drug Targets; 2011 Jun; 12(6):790-9. PubMed ID: 21269269 [TBL] [Abstract][Full Text] [Related]
11. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease. Corona JC; Duchen MR Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979 [TBL] [Abstract][Full Text] [Related]
12. The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. Bonda DJ; Smith MA; Perry G; Lee HG; Wang X; Zhu X Curr Pharm Des; 2011; 17(31):3374-80. PubMed ID: 21902671 [TBL] [Abstract][Full Text] [Related]
13. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085 [TBL] [Abstract][Full Text] [Related]
14. Protective Mechanisms of Flavonoids in Parkinson's Disease. Magalingam KB; Radhakrishnan AK; Haleagrahara N Oxid Med Cell Longev; 2015; 2015():314560. PubMed ID: 26576219 [TBL] [Abstract][Full Text] [Related]
15. The multi-faceted role of mitochondria in the pathology of Parkinson's disease. Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931 [TBL] [Abstract][Full Text] [Related]
16. Reduction of ER-Mitochondria Distance: a Key Feature in Alzheimer's and Parkinson's Disease, and During Cancer Treatment. Perez-Leanos CA; Romero-Campos HE; Dupont G; Gonzalez-Velez V Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4412-4415. PubMed ID: 34892198 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate. Dixit S; Fessel JP; Harrison FE Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial retrograde signaling in the nervous system. Hunt RJ; Bateman JM FEBS Lett; 2018 Mar; 592(5):663-678. PubMed ID: 29086414 [TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders. Khan MM; Paez HG; Pitzer CR; Alway SE Curr Neuropharmacol; 2023; 21(5):1100-1116. PubMed ID: 36089791 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic intervention at cellular quality control systems in Alzheimer's and Parkinson's diseases. Arduino DM; Esteves AR; Silva DF; Martins-Branco D; Santos D; Pimentel DF; Cardoso SM Curr Pharm Des; 2011; 17(31):3446-59. PubMed ID: 21902664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]